Eye News and Research

Latest Eye News and Research

Diabetics more likely to lose their vision

Experts in the United States have found that vision loss is more common in people with diabetes than those without the disease.

14 Oct 2008

Visual impairment more common in people with diabetes

Visual impairment appears to be more common in people with diabetes than in those without the disease, according to a report in the October issue of Archives of Ophthalmology.

13 Oct 2008

Prevalence of vitamin D insufficiency in patients with Parkinson's and Alzheimer's disease

A majority of Parkinson's disease patients had insufficient levels of vitamin D in a new study from Emory University School of Medicine.

13 Oct 2008

People lacking vital antioxidants and exposed to sunlight more likely to develop eye disease later in life

People who lack essential antioxidants, and who have high levels of sunlight exposure, have a higher risk of developing advanced macular degeneration (AMD), according to a study published today in the journal Archives of Ophthalmology. AMD is the leading cause of poor vision in the UK.

13 Oct 2008

Quark Pharmaceuticals' siRNAs examined alone and in xombination with chemotherapy

Quark Pharmaceuticals, Inc. has announced that the journal Cancer Research published results on efficacy of siRNA targeting its proprietary target gene against non-small cell lung cancer (NSCLC) in the edition dated October 1, 2008.

12 Oct 2008

Landmark study unlocks stem cell, DNA secrets to speed therapies

In a groundbreaking study led by an eminent molecular biologist at Florida State University, researchers have discovered that as embryonic stem cells turn into different cell types, there are dramatic corresponding changes to the order in which DNA is replicated and reorganized.

12 Oct 2008

FDA approves Rapaflo for treatment of symptoms due to benign prostatic hyperplasia

The U.S. Food and Drug Administration today approved Rapaflo (silodosin) capsules for the treatment of symptoms due to benign prostatic hyperplasia (BPH), a condition also known as an enlarged prostate.

12 Oct 2008

Research shows how cornea uses stem cells to repair itself

A group of researchers in Lausanne, Switzerland has published a study appearing in the Oct 1 advance online edition of the Journal Nature that shows how the cornea uses stem cells to repair itself.

2 Oct 2008

Mammograms read by computers will boost cancer detection and reduce doctors' workload

A computer can safely replace a medical expert in a revolutionary way of interpreting a breast X-ray - according to a Cancer Research UK funded study.

2 Oct 2008

Cholesterol research, begun in the 'Little Skate,' Garners Award

New research on the way the body processes cholesterol has earned a scientist at the University of Rochester Medical Center one of the highest honors in the field.

2 Oct 2008

First genetic research model of retina receptors

A team of scientists at the University of Oklahoma Health Sciences Center has created the first genetic research model for a microscopic part of the eye that when missing causes blindness. The research appears in a recent issue of the Journal of Biological Chemistry.

30 Sep 2008

'Eyes tight shut case' confounds experts

The case of an Australian woman unable to open her eyes on three days of each week is confounding doctors.

30 Sep 2008

No blood needed thanks to non-invasive blood monitoring device

A non-invasive blood monitoring device that removes the need to draw blood to monitor patients has won the 2008 Kerrin Rennie Award for Excellence in Medical Technology. The award was presented to Masimo Corporation on 24 September at the Medical Technology Association of Australia (MTAA) dinner in Sydney.

28 Sep 2008

Infants who focus on mouths rather eyes could be autistic

Researchers in the United States say young children who focus on mouths rather than on eyes could be autistic and they believe the extent of such behaviour indicates the severity of the Autism Spectrum Disorder.

28 Sep 2008

Data Safety Monitoring Board supports continuation of trial of Iluvien for diabetic macular edema

pSivida Corp. has announced that after completing its review of safety and efficacy data currently available, an independent Data Safety Monitoring Board (DSMB) has once again recommended that the two pivotal Phase III clinical trials, known collectively as the FAME (Fluocinolone Acetonide in Diabetic Macular Edema) Study continue under the current protocol, without change.

25 Sep 2008